ArticleFrontiers in surgery2025
Type 3A free anterolateral thigh chimeric flap based on the Zunyi classification for reconstructing diabetic foot wounds.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- [Clinical effects of harvesting superficial circumflex iliac artery PSP flaps via the subdermal approach to repair skin and soft tissue defects in hands and feet].Zhonghua shao shang yu chuang mian xiu fu za zhi · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetic foot wounds (DFWs) often present with multilayered tissue loss involving skin, fascia, muscle, and neurovascular structures, posing substantial reconstructive challenges. The Zunyi Classification provides a function-oriented framework for chimeric anterolateral thigh (ALT) flap design. This study aimed to evaluate the clinical efficacy of the Zunyi Type 3A chimeric ALT flap in the reconstruction of complex DFWs. Methods: A retrospective cohort study was carried out involving 28 patients with Wagner grade 2-4 DFWs who underwent reconstruction using a Zunyi Type 3A chimeric ALT flap between June 2021 and June 2024. All flaps were designed based on a single perforator without skin paddle segmentation. Flap composition was tailored to defect characteristics, incorporating combinations of skin, fascia lata, muscle, and sensory nerve. Primary outcomes included flap survival, complication rate, donor-site morbidity, and long-term functional outcome. Results: Among the 28 patients with Wagner grade 2-4 DFWs, the most common flap composition was skin + fascia lata + muscle (S + F + M), applied in 17 cases (60.7%). This was followed by skin + muscle + sensory nerve (S + M + N) in 6 cases (21.4%) and skin + fascia lata + sensory nerve (S + F + N) in 5 cases (17.9%). Flap survival was excellent, with 96.4% demonstrating complete viability; one case of partial distal necrosis was managed successfully with debridement and skin grafting. No donor-site complications were observed. During a median follow-up of 13 months (range: 3-30), none of the patients had ulcer recurrence, major infection, or limb-threatening events occurred. Most patients regained satisfactory ambulatory function while preserving limb integrity. Conclusions: The Zunyi Type 3A chimeric ALT flap offers a reliable, adaptable solution for limb salvage in patients with advanced DFWs. Its capacity to incorporate multiple tissue types in a single, unsegmented design offers effective coverage, structural support, and long-term durability. These findings support broader clinical application of the Zunyi Classification in personalized reconstructive strategies for complex DFWs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.